These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29856795)

  • 1. Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study.
    van Geel TACM; Bliuc D; Geusens PPM; Center JR; Dinant GJ; Tran T; van den Bergh JPW; McLellan AR; Eisman JA
    PLoS One; 2018; 13(6):e0198006. PubMed ID: 29856795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality.
    Huntjens KM; van Geel TA; van den Bergh JP; van Helden S; Willems P; Winkens B; Eisman JA; Geusens PP; Brink PR
    J Bone Joint Surg Am; 2014 Feb; 96(4):e29. PubMed ID: 24553898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bisphosphonates are associated with reduced mortality after hip fracture.
    Beaupre LA; Morrish DW; Hanley DA; Maksymowych WP; Bell NR; Juby AG; Majumdar SR
    Osteoporos Int; 2011 Mar; 22(3):983-91. PubMed ID: 21052642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study.
    González-Quevedo D; Bautista-Enrique D; Pérez-Del-Río V; Bravo-Bardají M; García-de-Quevedo D; Tamimi I
    Osteoporos Int; 2020 Jan; 31(1):77-84. PubMed ID: 31511912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.
    Park-Wyllie LY; Mamdani MM; Juurlink DN; Hawker GA; Gunraj N; Austin PC; Whelan DB; Weiler PJ; Laupacis A
    JAMA; 2011 Feb; 305(8):783-9. PubMed ID: 21343577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
    Gamboa A; Duaso E; Marimón P; Sandiumenge M; Escalante E; Lumbreras C; Tarrida A
    Osteoporos Int; 2018 Oct; 29(10):2309-2314. PubMed ID: 30076454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of oral bisphosphonates in primary prevention of fractures in postmenopausal women: a population-based cohort study.
    Real J; Galindo G; Galván L; Lafarga MA; Rodrigo MD; Ortega M
    PLoS One; 2015; 10(4):e0118178. PubMed ID: 25861000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC; Lu HT; Dusetzina SB; Wu CH
    J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses.
    Amiche MA; Lévesque LE; Gomes T; Adachi JD; Cadarette SM
    J Bone Miner Res; 2018 Mar; 33(3):419-429. PubMed ID: 29068496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.
    Brozek W; Reichardt B; Zwerina J; Dimai HP; Klaushofer K; Zwettler E
    Osteoporos Int; 2016 Jan; 27(1):387-96. PubMed ID: 26576544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates and mortality: confounding in observational studies?
    Bergman J; Nordström A; Hommel A; Kivipelto M; Nordström P
    Osteoporos Int; 2019 Oct; 30(10):1973-1982. PubMed ID: 31367949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
    Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.
    Bliuc D; Nguyen ND; Milch VE; Nguyen TV; Eisman JA; Center JR
    JAMA; 2009 Feb; 301(5):513-21. PubMed ID: 19190316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple simultaneous fractures are associated with higher all-cause mortality: results from a province-wide fracture liaison service.
    Sujic R; Luo J; Beaton DE; Bogoch ER; Sale JEM; Jaglal S; Jain R; Mamdani M;
    Osteoporos Int; 2020 Feb; 31(2):291-296. PubMed ID: 31720710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.
    Yong JH; Masucci L; Hoch JS; Sujic R; Beaton D
    Osteoporos Int; 2016 Jan; 27(1):231-40. PubMed ID: 26275439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate Use After Hip Fracture in Older Adults: A Nationwide Retrospective Cohort Study.
    Nordström P; Toots A; Gustafson Y; Thorngren KG; Hommel A; Nordström A
    J Am Med Dir Assoc; 2017 Jun; 18(6):515-521. PubMed ID: 28238673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
    Modi A; Tang J; Sen S; Díez-Pérez A
    Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
    Chesnut CH; Skag A; Christiansen C; Recker R; Stakkestad JA; Hoiseth A; Felsenberg D; Huss H; Gilbride J; Schimmer RC; Delmas PD;
    J Bone Miner Res; 2004 Aug; 19(8):1241-9. PubMed ID: 15231010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
    Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
    Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate.
    Nakayama A; Major G; Holliday E; Attia J; Bogduk N
    Osteoporos Int; 2016 Mar; 27(3):873-879. PubMed ID: 26650377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.